Literature DB >> 26499169

Periplanosides A-C: new insect-derived dihydroisocoumarin glucosides from Periplaneta americana stimulating collagen production in human dermal fibroblasts.

Yong-Xun Yang1,2, Qi Luo1, Bo Hou1, Yong-Ming Yan1, Yue-Hu Wang1, Jian-Jun Tang1, Xiao-Ping Dong2, Xiu-Ying Ma3, Tong-Hua Yang4, Zhi-Li Zuo1, Yong-Xian Cheng1,2.   

Abstract

Three new dihydroisocoumarin glucosides, termed periplanosides A-C (1-3), a known analog, pericanaside (4), and the other twenty known compounds were isolated from the insect Periplaneta americana. Their structures including absolute configurations were determined by comprehensive spectroscopic analyses and computational methods. Biological evaluation showed that compound 2 could stimulate collagen production by 31.2% in human dermal fibroblasts-adult (HDFa) at the concentration of 30 μM, indicating its significance in skin repair and ulcer.

Entities:  

Keywords:  Periplaneta americana; collagen I production; human dermal fibroblasts-adult; insect; isocoumarin

Mesh:

Substances:

Year:  2015        PMID: 26499169     DOI: 10.1080/10286020.2015.1047771

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  3 in total

1.  Bioactivity-Guided Screening of Wound-Healing Active Constituents from American Cockroach (Periplaneta americana).

Authors:  Juan-Juan Zhu; Shun Yao; Xin Guo; Bi-Song Yue; Xiu-Ying Ma; Jing Li
Journal:  Molecules       Date:  2018-01-20       Impact factor: 4.411

2.  The Regulating Effect of CII-3 and Its Active Components from Periplaneta americana on M1/M2 Macrophage Polarization.

Authors:  Jinglei Xu; Yihao Che; Xinyue Liu; Chaohe Liu; Di Meng; Xiuqin Pang; Miao He; Guangming Liu; Chenggui Zhang; Dasong Yang; Huai Xiao
Journal:  Molecules       Date:  2022-07-10       Impact factor: 4.927

Review 3.  KangFuXin Liquid in the Treatment of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis.

Authors:  Ke Shen Qu; Yang Li; Yue Liang; Xiao Jie Hu; Xuan Yu Wang; Xin Chen; Hua Fa Que
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-30       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.